Purchases and Sales Made in Q1 2024 in Voyager Therapeutics, Inc. (VYGR)
This table provides information about the institutional ownership of Voyager Therapeutics, Inc. (VYGR) during Q1 2024. The information is specifically focused on institutions that hold shares of Voyager Therapeutics, Inc..
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
May 15, 2024
Q1 2024
|
Tower Research Capital LLC (Trc)
New York, NY |
SELL
|
- |
-5.98K- 93.45% |
$42.8K - $64.8K
|
419
$1.63K
|
|
|
May 13, 2024
Q1 2024
|
O'Shaughnessy Asset Management, LLC
Stamford, CT |
SELL
|
- |
-6.02K- 21.59% |
$43K - $65.2K
|
21.8K
$85.2K
|
|
|
Feb 07, 2025
Q1 2024
|
Voya Investment Management LLC
Atlanta, GA |
SELL
|
- |
-6.1K- 37.54% |
$43.6K - $66.2K
|
10.2K
$39.6K
|
|
|
Dec 06, 2024
Q1 2024
|
Voya Investment Management LLC
Atlanta, GA |
SELL
|
- |
-6.1K- 37.54% |
$43.6K - $66.2K
|
10.2K
$39.6K
|
|
|
May 14, 2024
Q1 2024
|
Alliancebernstein L.P.
New York, NY |
SELL
|
- |
-6.32K- 28.82% |
$45.2K - $68.5K
|
15.6K
$60.9K
|
|
|
May 10, 2024
Q1 2024
|
Jpmorgan Chase & CO
New York, NY |
SELL
|
- |
-6.87K- 2.12% |
$49.1K - $74.5K
|
317K
$1.23M
|
|
|
May 15, 2024
Q1 2024
|
Barclays PLC
London, X0 |
SELL
|
- |
-7.19K- 10.86% |
$51.4K - $77.9K
|
59K
$230K
|
|
|
May 14, 2024
Q1 2024
|
Entry Point Capital, LLC
New York, NY |
SELL
|
- |
-10.7K- 51.56% |
$76.4K - $116K
|
10K
$39.2K
|
|
|
May 07, 2024
Q1 2024
|
Susquehanna International Group, LLP
Bala Cynwyd, PA |
SELL
|
- |
-11.2K- 23.78% |
$80.2K - $122K
|
35.9K
$140K
|
|
|
May 14, 2024
Q1 2024
|
Aviva PLC
|
SELL
|
- |
-12.5K- 15.1% |
$89.4K - $135K
|
70.3K
$274K
|
|
|
May 14, 2024
Q1 2024
|
Vestcor Inc
Fredericton, A3 |
SELL
|
- |
-15.3K- 40.01% |
$109K - $165K
|
22.9K
$89.2K
|
|
|
May 14, 2024
Q1 2024
|
Globeflex Capital L P
San Diego, CA |
SELL
|
- |
-21.8K- 6.57% |
$156K - $236K
|
310K
$1.21M
|
|
|
May 14, 2024
Q1 2024
|
Qube Research & Technologies LTD
London, X0 |
SELL
|
- |
-26.8K- 78.3% |
$191K - $290K
|
7.41K
$28.9K
|
|
|
May 15, 2024
Q1 2024
|
Marshall Wace, LLP
London, X0 |
SELL
|
- |
-26.9K- 36.04% |
$193K - $292K
|
47.8K
$186K
|
|
|
May 15, 2024
Q1 2024
|
Boothbay Fund Management, LLC
New York, NY |
SELL
|
- |
-27.4K- 40.87% |
$196K - $297K
|
39.6K
$155K
|
|
|
May 13, 2024
Q1 2024
|
Advantage Alpha Capital Partners LP
San Francisco, CA |
SELL
|
- |
-54.6K- 30.85% |
$390K - $591K
|
122K
$477K
|
|
|
May 13, 2024
Q1 2024
|
Jim Simons
Renaissance Technologies LLC | New York, Ny
|
SELL
|
- |
-55K- 30.04% |
$393K - $596K
|
128K
$500K
|
|
|
May 15, 2024
Q1 2024
|
Adar1 Capital Management, LLC
Austin, TX |
SELL
|
- |
-94.4K- 50.76% |
$675K - $1.02M
|
91.5K
$357K
|
|
|
May 15, 2024
Q1 2024
|
Ikarian Capital, LLC
Dallas, TX |
SELL
|
- |
-125K- 40.87% |
$894K - $1.36M
|
181K
$705K
|
|
|
May 15, 2024
Q1 2024
|
D. E. Shaw & Co., Inc.
New York, NY |
SELL
|
- |
-172K- 42.37% |
$1.23M - $1.87M
|
234K
$913K
|
|
|
Oct 17, 2024
Q1 2024
|
Morgan Stanley
New York, NY |
SELL
|
- |
-215K- 43.22% |
$1.54M - $2.33M
|
282K
$1.1M
|